New Health Sciences, Inc.

About the Company: New Health Sciences is a fast growing and exciting working environment that foments design thinking as it strives to provide the best positive outcomes for patients treated with its products. Located at its vibrant site in the Kendall Square area of Cambridge, it is able to draw a talented team with unity and purpose. Currently in research and development, Hemanext™ is a novel, proprietary anaerobic storage system that helps minimizes oxidative damage to red blood cells (RBC) in storage and has the potential to help certain patient populations that may benefit from a higher quality red cell at time of transfusion. Current RBC collection process and storage conditions allow RBC to exhibit cellular functional changes known as “the RBC storage lesion”. Stored RBCs, even if transfused within the current 6-week storage limit, deteriorate in a variety of significant ways. A significant contributor to the storage lesion is oxidative stress resulting from exposure of the RBCs to the oxygen present throughout the collection and storage period. The resulting aerobic storage environment allows the formation of reactive oxygen species that can cause harm to RBC proteins and membrane lipids. Hemanext aims to reduce oxidative stress to the RBC during storage and in doing so to improve the benefits to patients of RBC transfusion therapy. Visit the New Health Sciences, Inc. web site at www.newhealthsciences.com for more information.